{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:45:24Z","timestamp":1789771524812,"version":"4.0.1"},"reference-count":42,"publisher":"Walter de Gruyter GmbH","issue":"6","license":[{"start":{"date-parts":[[2014,5,4]],"date-time":"2014-05-04T00:00:00Z","timestamp":1399161600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s00005-014-0282-1","type":"journal-article","created":{"date-parts":[[2014,5,3]],"date-time":"2014-05-03T07:28:55Z","timestamp":1399102135000},"page":"501-509","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["The Role of Serum C-Reactive Protein Measured by High-Sensitive Method in Thyroid Disease"],"prefix":"10.2478","volume":"62","author":[{"given":"Agata","family":"Czarnywojtek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Owecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Zgorzalewicz-Stachowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosma","family":"Woli\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewelina","family":"Szczepanek-Parulska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart\u0142omiej","family":"Budny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Florek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Walig\u00f3rska-Stachura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela","family":"Miechowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"B\u0105czyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Sawicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Dhir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Rucha\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2014,5,4]]},"reference":[{"key":"282_CR1","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa021735","volume":"348","author":"JA Baron","year":"2003","unstructured":"Baron JA, Cole BF, Sandler RS et al (2003) A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 348:891\u2013899","journal-title":"N Engl J Med"},{"key":"282_CR2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/thy.2007.0315","volume":"18","author":"L Bartalena","year":"2008","unstructured":"Bartalena L, Baldeschi L, Dickinson AJ et al (2008) Consensus statement of the European group on Graves\u2019 orbitopathy (EUGOGO) on management of Graves\u2019 orbitopathy. Thyroid 18:333\u2013346","journal-title":"Thyroid"},{"key":"282_CR3","first-page":"312","volume":"60","author":"T Bednarczuk","year":"2009","unstructured":"Bednarczuk T, Bar-Andziak E, Hubalewska-Dydejczyk A et al (2009) Management of Graves\u2019 orbitopathy. Comments on the EUGOGO consensus statement. Endokrynol Pol 60:312\u2013330","journal-title":"Endokrynol Pol"},{"key":"282_CR4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1530\/EJE-12-0627","volume":"167","author":"B Biondi","year":"2012","unstructured":"Biondi B (2012) Mechanisms in endocrinology: heart failure and thyroid dysfunction. Eur J Endocrinol 167:609\u2013618","journal-title":"Eur J Endocrinol"},{"key":"282_CR5","doi-asserted-by":"crossref","first-page":"904","DOI":"10.7326\/0003-4819-137-11-200212030-00011","volume":"137","author":"B Biondi","year":"2002","unstructured":"Biondi B, Palmieri EA, Lombardi G et al (2002) Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 137:904\u2013914","journal-title":"Ann Intern Med"},{"key":"282_CR6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0021-9150(02)00372-6","volume":"166","author":"M Christ-Crain","year":"2003","unstructured":"Christ-Crain M, Meier C, Guglielmetti M et al (2003) Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis 166:379\u2013386","journal-title":"Atherosclerosis"},{"key":"282_CR7","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jama.291.5.585","volume":"291","author":"TP Erlinger","year":"2004","unstructured":"Erlinger TP, Platz EA, Rifai N et al (2004) C-reactive protein and the risk of incident colorectal cancer. JAMA 291:585\u2013590","journal-title":"JAMA"},{"key":"282_CR8","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJM199803123381103","volume":"338","author":"JA Franklyn","year":"1998","unstructured":"Franklyn JA, Maisonneuve P, Sheppard MC et al (1998) Mortality after the treatment of hyperthyroidism with radioactive iodine. N Engl J Med 338:712\u2013718","journal-title":"N Engl J Med"},{"key":"282_CR9","doi-asserted-by":"crossref","first-page":"e6242","DOI":"10.1371\/journal.pone.0006242","volume":"4","author":"J Graf","year":"2009","unstructured":"Graf J, Scherzer R, Grunfeld C et al (2009) Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis. PLoS ONE 4:e6242","journal-title":"PLoS ONE"},{"key":"282_CR10","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1399-0012.2010.01345.x","volume":"25","author":"SO Grebe","year":"2011","unstructured":"Grebe SO, Kuhlmann U, Fogl D et al (2011) Macrophage activation is associated with poorer long-term outcomes in renal transplant patients. Clin Transplant 25:744\u2013754","journal-title":"Clin Transplant"},{"key":"282_CR11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-132-4-200002150-00004","volume":"132","author":"AE Hak","year":"2000","unstructured":"Hak AE, Pols HA, Visser TJ et al (2000) Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 132:270\u2013278","journal-title":"Ann Intern Med"},{"key":"282_CR12","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.2337\/diacare.25.11.2016","volume":"25","author":"TS Han","year":"2002","unstructured":"Han TS, Sattar N, Williams K et al (2002) Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 25:2016\u20132021","journal-title":"Diabetes Care"},{"key":"282_CR13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4137\/BMI.S10092","volume":"7","author":"MH Hopkins","year":"2012","unstructured":"Hopkins MH, Flanders WD, Bostick RM (2012) Associations of circulating inflammatory biomarkers with risk factors for colorectal cancer in colorectal adenoma patients. Biomark Insights 7:143\u2013150","journal-title":"Biomark Insights"},{"key":"282_CR14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/01.mco.0000241663.00267.ae","volume":"9","author":"MJ J\u00e4rvisalo","year":"2006","unstructured":"J\u00e4rvisalo MJ, Juonala M, Raitakari OT (2006) Assessment of inflammatory markers and endothelial function. Curr Opin Clin Nutr Metab Care 9:547\u2013552","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"282_CR15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.atherosclerosis.2003.09.009","volume":"172","author":"C Jublanc","year":"2004","unstructured":"Jublanc C, Bruckert E, Giral P et al (2004) Relationship of circulating C-reactive protein levels to thyroid status and cardiovascular risk in hyperlipidemic euthyroid subjects: low free thyroxine is associated with elevated hsCRP. Atherosclerosis 172:7\u201311","journal-title":"Atherosclerosis"},{"key":"282_CR16","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1089\/thy.2010.0333","volume":"22","author":"G Kaminski","year":"2012","unstructured":"Kaminski G, Makowski K, Micha\u0142kiewicz D et al (2012) The influence of subclinical hyperthyroidism on blood pressure, heart rate variability, and prevalence of arrhythmias. Thyroid 22:454\u2013460","journal-title":"Thyroid"},{"key":"282_CR17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM200105103441901","volume":"344","author":"I Klein","year":"2001","unstructured":"Klein I, Ojamaa K (2001) Thyroid hormone and the cardiovascular system. N Engl J Med 344:501\u2013509","journal-title":"N Engl J Med"},{"key":"282_CR18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1373\/clinchem.2007.100271","volume":"54","author":"W Koenig","year":"2008","unstructured":"Koenig W, Khuseyinova N, Baumert J et al (2008) Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: results from the MONICA\/KORA Augsburg Cohort Study, 1984\u20131998. Clin Chem 54:335\u2013342","journal-title":"Clin Chem"},{"key":"282_CR19","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jbiosc.2012.06.005","volume":"114","author":"T Komoriya","year":"2012","unstructured":"Komoriya T, Inoue N, Yoshimune K et al (2012) Use of a highly sensitive latex reagent with amino acid spacer for determination of C-reactive protein concentration in a variety of liver diseases. J Biosci Bioeng 114:560\u2013563","journal-title":"J Biosci Bioeng"},{"key":"282_CR20","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00125-004-1472-x","volume":"47","author":"DE Laaksonen","year":"2004","unstructured":"Laaksonen DE, Niskanen L, Nyyssonen K et al (2004) C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia 47:1403\u20131410","journal-title":"Diabetologia"},{"key":"282_CR21","doi-asserted-by":"crossref","first-page":"H2031","DOI":"10.1152\/ajpheart.01058.2004","volume":"288","author":"DC Lau","year":"2005","unstructured":"Lau DC, Dhillon B, Yan H et al (2005) Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 288:H2031\u2013H2041","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"282_CR22","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1210\/jc.2006-2321","volume":"92","author":"S Metso","year":"2007","unstructured":"Metso S, Jaatinen P, Huhtala H et al (2007) Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism. J Clin Endocrinol Metab 92:2190\u20132196","journal-title":"J Clin Endocrinol Metab"},{"key":"282_CR23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.biopha.2006.10.008","volume":"61","author":"T Nagasaki","year":"2007","unstructured":"Nagasaki T, Inaba M, Shirakawa K et al (2007) Increased levels of C-reactive protein in hypothyroid patients and its correlation with arterial stiffness in the common carotid artery. Biomed Pharmacother 61:167\u2013172","journal-title":"Biomed Pharmacother"},{"key":"282_CR24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.metabol.2007.09.002","volume":"57","author":"A Onat","year":"2008","unstructured":"Onat A, Can G, Hergenc G (2008) Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk. Metabolism 57:207\u2013214","journal-title":"Metabolism"},{"key":"282_CR25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.20452\/pamw.1261","volume":"122","author":"D Owczarek","year":"2012","unstructured":"Owczarek D, Cibor D, Sa\u0142apa K et al (2012) Anti-inflammatory and anticoagulant properties of the protein C system in inflammatory bowel disease. Pol Arch Med Wewn 122:209\u2013216","journal-title":"Pol Arch Med Wewn"},{"key":"282_CR26","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(01)06067-6","volume":"358","author":"JV Parle","year":"2001","unstructured":"Parle JV, Maisonneuve P, Sheppard MC et al (2001) Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 358:861\u2013865","journal-title":"Lancet"},{"key":"282_CR27","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/105072503322239989","volume":"13","author":"EN Pearce","year":"2003","unstructured":"Pearce EN, Bogazzi F, Martino E et al (2003) The prevalence of elevated serum C-reactive protein levels in inflammatory and noninflammatory thyroid disease. Thyroid 13:643\u2013648","journal-title":"Thyroid"},{"key":"282_CR28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0140-6736(81)91565-8","volume":"1","author":"MB Pepys","year":"1981","unstructured":"Pepys MB (1981) C-reactive protein. Fifty years on. Lancet 1:653\u2013657","journal-title":"Lancet"},{"key":"282_CR29","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","volume":"111","author":"MB Pepys","year":"2003","unstructured":"Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111:1805\u20131812","journal-title":"J Clin Invest"},{"key":"282_CR30","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/archinte.160.13.1993","volume":"160","author":"A Peters","year":"2000","unstructured":"Peters A, Ehlers M, Blank B et al (2000) Excess triiodothyronine as a risk factor of coronary events. Arch Intern Med 160:1993\u20131999","journal-title":"Arch Intern Med"},{"key":"282_CR31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.286.3.327","volume":"286","author":"AD Pradhan","year":"2001","unstructured":"Pradhan AD, Manson JE, Rifai N et al (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327\u2013334","journal-title":"JAMA"},{"key":"282_CR32","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1177\/0961203311418706","volume":"20","author":"Z Rezaieyazdi","year":"2011","unstructured":"Rezaieyazdi Z, Sahebari M, Hatef MR et al (2011) Is there any correlation between high sensitive CRP and disease activity in systemic lupus erythematosus? Lupus 20:1494\u20131500","journal-title":"Lupus"},{"key":"282_CR33","first-page":"214","volume":"85","author":"PM Ridker","year":"2000","unstructured":"Ridker PM, Paul S, Wild RA et al (2000) The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in helthy postmenopausal woman: a randomized, controlled tral. J Ciln Endocrinol Metab 85:214\u2013218","journal-title":"J Ciln Endocrinol Metab"},{"key":"282_CR34","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","volume":"359","author":"PM Ridker","year":"2008","unstructured":"Ridker PM, Danielson E, Fonseca FA et al (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359:2195\u20132207","journal-title":"N Engl J Med"},{"key":"282_CR35","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s11255-011-0098-4","volume":"44","author":"A Roshdy","year":"2012","unstructured":"Roshdy A, El-Khatib MM, Rizk MN et al (2012) CRP and acute renal rejection: a marker to the point. Int Urol Nephrol 44:1251\u20131255","journal-title":"Int Urol Nephrol"},{"key":"282_CR36","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/01.ATV.20.4.1057","volume":"20","author":"TE Strandberg","year":"2000","unstructured":"Strandberg TE, Tilvis RS (2000) C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arterioscler Thromb Vasc Biol 20:1057\u20131060","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"282_CR37","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1530\/EJE-08-0553","volume":"159","author":"ML Tanda","year":"2008","unstructured":"Tanda ML, Bogazzi F, Martino E et al (2008) Amiodarone-induced thyrotoxicosis: something new to refine the initial diagnosis? Eur J Endocrinol 159:359\u2013361","journal-title":"Eur J Endocrinol"},{"key":"282_CR38","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1084\/jem.52.4.561","volume":"52","author":"WS Tillett","year":"1930","unstructured":"Tillett WS, Francis T Jr (1930) Serological reactions in pneumonia with a nonprotein somatic fraction of pneumococcus. J Exp Med 52:561\u2013585","journal-title":"J Exp Med"},{"key":"282_CR39","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/heart.84.4.455","volume":"84","author":"AD Toft","year":"2000","unstructured":"Toft AD, Boon NA (2000) Thyroid disease and the heart. Heart 84:455\u2013460","journal-title":"Heart"},{"key":"282_CR40","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3899\/jrheum.100735","volume":"38","author":"G Tomasson","year":"2011","unstructured":"Tomasson G, Lavalley M, Tanriverdi K et al (2011) Wegener\u2019s Granulomatosis Etanercept Trial (WGET) Research Group Relationship between markers of platelet activation and inflammation with disease activity in Wegener\u2019s granulomatosis. J Rheumatol 38:1048\u20131054","journal-title":"J Rheumatol"},{"key":"282_CR41","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/clinchem\/40.6.934","volume":"40","author":"JT Whicher","year":"1994","unstructured":"Whicher JT, Ritchie RF, Johnson AM et al (1994) New international reference preparation for proteins in human serum (RPPHS). Clin Chem 40:934\u2013938","journal-title":"Clin Chem"},{"key":"282_CR42","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0009-9120(00)00186-7","volume":"33","author":"H Yu","year":"2000","unstructured":"Yu H, Rifai N (2000) High-sensitivity C-reactive protein and athosclerosis: from theory to therapy. Clin Biochem 33:601\u2013610","journal-title":"Clin Biochem"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-014-0282-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-014-0282-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-014-0282-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T17:26:26Z","timestamp":1746206786000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-014-0282-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,4]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["282"],"URL":"https:\/\/doi.org\/10.1007\/s00005-014-0282-1","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,4]]}}}